electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic
medicine company, today announced a patient education initiative in
partnership with HealthyWomen, the nation’s leading independent,
nonprofit health information source for women, to increase
awareness around non-drug treatment options for migraine pain in
female patients.
The initiative is driven by results from an
electroCore-HealthyWomen partnered survey, which showed there is a
significant lack of awareness of non-drug treatment options for
migraine among female patients. According to the survey of over
1,000 female migraine patients between the ages of 18 and 60 years
old, 86 percent of patients are completely or somewhat willing to
try non-drug treatments, however, only 36 percent expressed
awareness of non-drug treatment options.
To bridge this knowledge gap surrounding the availability and
utility of non-drug treatment options, HealthyWomen and electroCore
have developed a suite of content which can be found at
HealthyWomen.org/migraine designed to educate women who suffer from
migraine and to empower them to initiate a conversation with their
HCP about the use of non-drug therapies in their own treatment
plan.
“This important survey clearly demonstrates that there is a
strong demand among women for non-drug treatment options,” said
Frank Amato, chief executive officer of electroCore. “With 70
percent of all migraine sufferers4 and 85 percent of chronic
migraine sufferers being women1, it is essential that we educate
both providers and patients in the migraine community about safer
alternative options like non-invasive vagus nerve stimulation
(nVNS). The collaboration with HealthyWomen is an important step in
educating women about their health and bringing non-drug treatment
options into the forefront.”
Additional findings from the electroCore-HealthyWomen partnered
survey support the importance of patient education regarding
non-drug treatments in migraine since fewer than 18 percent of
patients said they are completely satisfied with their migraine
treatment:
- 76 percent of patients noted migraines interfere with their
daily activities
- Over 90 percent of sufferers typically try multiple treatments
for their migraines, and nearly half (48 percent) have tried 4 or
more
- 86 percent of patients initiated the conversation regarding
migraine treatment with their HCP
As an organization committed to helping educate and empower
women to act upon information related to their health, HealthyWomen
has partnered on the survey and the suite of resulting content to
further inform women about non-drug migraine treatment options.
When armed with information, women who suffer from migraine may
feel more confident to have the conversation with their HCP about
all available treatment options when it comes to managing their
pain.
“As women, we are often the driving forces behind making
critical decisions about our own medical care and the corresponding
questions and concerns that may arise, which can be intimidating.”
said Beth Battaglino, RN-C, chief executive officer of
HealthyWomen. “However, the vast majority of female migraine
sufferers initiate the conversation regarding migraine treatment
options with their HCPs. Increasing access to up-to-date
information about migraine treatment options will allow women to
gain more control over the treatment decision making process and
work with their HCP to ultimately find the best treatment
option.”
Deborah I. Friedman, MD, MPH, FAAN, Professor of Neurology &
Neurotherapeutics and Ophthalmology at the University of Texas
Southwestern Medical Center agrees on the importance, “Migraine is
one of the most prevalent diseases worldwide, especially among
women1. It is essential that patients are equipped with the
necessary knowledge to address the potential efficacy of treatments
with their health care provider, whether it is a non-drug or
pharmaceutical option, especially if it can mean relief from
debilitating symptoms. This survey shows a need for increased
communication between HCPs and their patients, and I am pleased
that there are new educational resources available in order to make
these discussions more productive.”
To explore the patient resources, learn more about the survey
findings and learn about one patient’s journey with nVNS to treat
migraine, visit https://www.healthywomen.org/migraine.
Survey MethodologySurveys were conducted by
HealthyWomen, sponsored by electroCore, of women who have been
diagnosed as having migraines and of nurse practitioners,
neurologists and headache specialists.
Patient Survey - A total of 1,005 female respondents between the
ages of 18 to 60 years old who have been diagnosed with migraines
by a health care professional were surveyed on:
- Experiences with migraine treatments
- Management of migraine symptoms
- Knowledge of non-drug migraine treatment options
- Impact of migraines on quality of life
HCP Survey - A total of 402 health care professionals were
surveyed on:
- Migraine treatments used
- Perceptions of patients
- Familiarity with the role of the vagus nerve in treating
migraines
About Migraine Migraine is a term used to
describe a class of recurrent, pulsing headaches that are typically
unilateral (on one side of the head) but may occur bilaterally (on
both sides of the head) and may cause visual disturbances, nausea
and vomiting.2 They may occur with or without recognized
warning signs, including either prodromal symptoms or an aura
phase.2 Prodromal symptoms consist of altered mood,
irritability, depression or euphoria, fatigue, dizziness and other
visceral symptoms preceding the headache by several hours or
days.3 Auras can include visual disturbances such as photopsia
or scotomas or, in less frequent cases, somatosensory, auditory or
gustatory hallucinations.3
There are approximately 39 million Americans living with
migraine, and more than 100,000 migraines occur every day in the
U.S.2,3 Migraine prevalence is significantly higher in females
than in males, at a ratio of 3-to-1.2 About
electroCore, Inc. electroCore, Inc. is a commercial-stage
bioelectronic medicine company dedicated to improving patient
outcomes through its platform non-invasive vagus nerve stimulation
therapy initially focused on the treatment of multiple conditions
in neurology and rheumatology. The company’s initial targets are
the preventative treatment of cluster headache and acute treatment
of migraine and episodic cluster headache.
For more information, visit www.electrocore.com.
About HealthyWomen HealthyWomen is the
nation's leading independent, nonprofit health information source
for women. Our mission is to educate women to make informed health
choices for themselves and for their families. For 30 years,
millions of women have turned to HealthyWomen for answers to their
most personal health care questions. HealthyWomen provides
objective, research-based health information reviewed by medical
experts to ensure its accuracy.
Nothing is more important to our health than access to competent
and affordable care and the safety of our medications and health
care delivery practices. HealthyWomen works to educate women about
health policy issues in these and other areas. We recognize the
importance of clinical trials to improving women's health and
support women's health research, particularly where sex may make a
difference in research results. HealthyWomen advocates on behalf of
women to ensure that women's health is a primary focus of policy
makers and advocacy groups. Our investment in developing
science-based information and our effort to incorporate
perspectives reflected by advances in research and technology will
further our mission to provide women with relevant and accurate
health resources. For more information, please visit
www.HealthyWomen.org. Follow us on Facebook, Twitter, Instagram and
LinkedIn.
Media ContactSara ZelkovicLifeSci Public
Relations(646) 876-4933Sara@lifescipublicrelations.com
1 Migraine in Women. Migraine Research Foundation.
https://migraineresearchfoundation.org/about-migraine/migraine-in-women/.
Accessed February 2019.
2 Migraine and Aura. American Migraine Foundation.
https://americanmigrainefoundation.org/understanding-migraine/migraine-and-aura/.
Accessed February 2019.
3 Global burden of migraine in the Year 2000: summary of methods
and data sources. World Health Organization.
http://www.who.int/healthinfo/statistics/bod_migraine.pdf. Accessed
February 2019.
4 Facts About Migraine. National Headache Foundation.
https://headaches.org/2005/08/12/facts-about-migraine/. Access
February 2019.
electroCore (NASDAQ:ECOR)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
electroCore (NASDAQ:ECOR)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024